IL-17A induces osteoblast differentiation by activating JAK2/STAT3 in ankylosing spondylitis

IL-17A has recently emerged as a potential target that regulates the extensive inflammation and abnormal bone formation observed in ankylosing spondylitis (AS). Blocking IL-17A is expected to inhibit bony anky...

Source: Arthritis Research and Therapy - June 7, 2018 Category: Rheumatology Authors: Sungsin Jo, Sung Eun Wang, Young Lim Lee, Suman Kang, Bitnara Lee, Jinil Han, Il-Hoon Sung, Ye-Soo Park, Sang-Cheol Bae and Tae-Hwan Kim Tags: Research article Source Type: research